Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 26,084 shares of the company’s stock, valued at approximately $1,927,000.
Several other hedge funds and other institutional investors have also modified their holdings of the business. Bessemer Group Inc. boosted its position in shares of Ryan Specialty by 2.5% in the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company’s stock worth $210,651,000 after buying an additional 79,976 shares during the period. Principal Financial Group Inc. increased its stake in Ryan Specialty by 66.4% in the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company’s stock valued at $225,404,000 after buying an additional 1,218,147 shares during the period. Geode Capital Management LLC increased its stake in Ryan Specialty by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company’s stock valued at $115,468,000 after buying an additional 46,960 shares during the period. Barclays PLC increased its stake in Ryan Specialty by 3.0% in the 4th quarter. Barclays PLC now owns 1,690,279 shares of the company’s stock valued at $108,449,000 after buying an additional 48,536 shares during the period. Finally, Stephens Investment Management Group LLC increased its stake in Ryan Specialty by 2.2% in the 1st quarter. Stephens Investment Management Group LLC now owns 1,642,527 shares of the company’s stock valued at $121,333,000 after buying an additional 34,932 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.
Insider Buying and Selling
In other Ryan Specialty news, Director David P. Bolger sold 5,000 shares of the firm’s stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the sale, the director directly owned 71,467 shares in the company, valued at $5,059,863.60. This trade represents a 6.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Mark Stephen Katz sold 14,377 shares of the firm’s stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. This represents a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 52.21% of the company’s stock.
Ryan Specialty Stock Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The company’s revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.35 EPS. As a group, analysts expect that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.
Ryan Specialty Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty’s dividend payout ratio (DPR) is currently 141.18%.
Wall Street Analyst Weigh In
RYAN has been the topic of several research reports. Morgan Stanley dropped their price objective on shares of Ryan Specialty from $80.00 to $78.00 and set an “overweight” rating on the stock in a research note on Monday, July 14th. Wells Fargo & Company dropped their price objective on shares of Ryan Specialty from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 10th. Wall Street Zen lowered shares of Ryan Specialty from a “hold” rating to a “sell” rating in a research note on Saturday, July 26th. The Goldman Sachs Group upgraded shares of Ryan Specialty from a “neutral” rating to a “buy” rating and upped their price objective for the company from $74.00 to $81.00 in a research note on Tuesday, May 13th. Finally, Barclays dropped their price objective on shares of Ryan Specialty from $83.00 to $79.00 and set an “overweight” rating on the stock in a research note on Monday, July 7th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $76.00.
Get Our Latest Stock Report on Ryan Specialty
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories
- Five stocks we like better than Ryan Specialty
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- How Marvell Went From Short Target to Breakout Star
- What Do S&P 500 Stocks Tell Investors About the Market?
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.